185 related articles for article (PubMed ID: 20734030)
1. Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model.
Goetghebeur PJ; Lerdrup L; Sylvest A; Dias R
Psychopharmacology (Berl); 2010 Dec; 212(4):635-42. PubMed ID: 20734030
[TBL] [Abstract][Full Text] [Related]
2. Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study.
Goetghebeur P; Dias R
Psychopharmacology (Berl); 2009 Jan; 202(1-3):287-93. PubMed ID: 18392753
[TBL] [Abstract][Full Text] [Related]
3. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
Pedersen CS; Goetghebeur P; Dias R
J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
Broberg BV; Glenthøj BY; Dias R; Larsen DB; Olsen CK
Psychopharmacology (Berl); 2009 Nov; 206(4):631-40. PubMed ID: 19390843
[TBL] [Abstract][Full Text] [Related]
5. Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task.
Laurent V; Podhorna J
Behav Pharmacol; 2004 Mar; 15(2):141-8. PubMed ID: 15096914
[TBL] [Abstract][Full Text] [Related]
6. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats.
McLean SL; Beck JP; Woolley ML; Neill JC
Behav Brain Res; 2008 May; 189(1):152-8. PubMed ID: 18282619
[TBL] [Abstract][Full Text] [Related]
7. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
Rodefer JS; Murphy ER; Baxter MG
Eur J Neurosci; 2005 Feb; 21(4):1070-6. PubMed ID: 15787711
[TBL] [Abstract][Full Text] [Related]
8. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.
Nikiforuk A; Popik P
Psychopharmacology (Berl); 2012 Mar; 220(1):65-74. PubMed ID: 21918808
[TBL] [Abstract][Full Text] [Related]
9. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.
Egerton A; Reid L; McKerchar CE; Morris BJ; Pratt JA
Psychopharmacology (Berl); 2005 Apr; 179(1):77-84. PubMed ID: 15682304
[TBL] [Abstract][Full Text] [Related]
10. The ultimate intra-/extra-dimensional attentional set-shifting task for mice.
Scheggia D; Bebensee A; Weinberger DR; Papaleo F
Biol Psychiatry; 2014 Apr; 75(8):660-70. PubMed ID: 23810621
[TBL] [Abstract][Full Text] [Related]
11. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.
Egerton A; Reid L; McGregor S; Cochran SM; Morris BJ; Pratt JA
Psychopharmacology (Berl); 2008 May; 198(1):37-49. PubMed ID: 18427784
[TBL] [Abstract][Full Text] [Related]
12. The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.
Janhunen SK; Svärd H; Talpos J; Kumar G; Steckler T; Plath N; Lerdrup L; Ruby T; Haman M; Wyler R; Ballard TM
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4059-83. PubMed ID: 26070547
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
14. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.
Abdul-Monim Z; Reynolds GP; Neill JC
J Psychopharmacol; 2003 Mar; 17(1):57-65. PubMed ID: 12680740
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC.
Baviera M; Invernizzi RW; Carli M
Psychopharmacology (Berl); 2008 Feb; 196(2):269-80. PubMed ID: 17940750
[TBL] [Abstract][Full Text] [Related]
16. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats.
Nikiforuk A; Gołembiowska K; Popik P
Eur Neuropsychopharmacol; 2010 Jan; 20(1):37-48. PubMed ID: 19729284
[TBL] [Abstract][Full Text] [Related]
17. 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats.
Hatcher PD; Brown VJ; Tait DS; Bate S; Overend P; Hagan JJ; Jones DN
Psychopharmacology (Berl); 2005 Sep; 181(2):253-9. PubMed ID: 15846482
[TBL] [Abstract][Full Text] [Related]
18. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine.
Sams-Dodd F
Neuropsychopharmacology; 1998 Apr; 18(4):293-304. PubMed ID: 9509497
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats.
Turgeon SM; Hulick VC
Pharmacol Biochem Behav; 2007 Mar; 86(3):524-30. PubMed ID: 17320157
[TBL] [Abstract][Full Text] [Related]
20. Impairment of intradimensional shift in an attentional set-shifting task in rats with chronic bilateral common carotid artery occlusion.
Kim DH; Choi BR; Jeon WK; Han JS
Behav Brain Res; 2016 Jan; 296():169-176. PubMed ID: 26365458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
